Literature DB >> 18462584

The molecular pathogenesis of Clostridium difficile-associated disease.

David A Bobak1.   

Abstract

Clostridium difficile-associated disease is a reemerging nosocomial disease of paramount importance not only in the United States, but most of the world as well. Recently, C. difficile-associated disease appears to be on the rise, with a parallel increase noted in its severity and extent. Although the main virulence factors, the large exotoxins known as toxin A and toxin B, have long been identified, only in the past few years has a near explosion of new information regarding the details of the toxin-mediated pathogenicity come to light. This update gives an overview of some of the more exciting and insightful reports published in the recent literature.

Entities:  

Year:  2008        PMID: 18462584     DOI: 10.1007/s11908-008-0020-0

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  43 in total

1.  Change of the donor substrate specificity of Clostridium difficile toxin B by site-directed mutagenesis.

Authors:  Thomas Jank; Dirk J Reinert; Torsten Giesemann; Georg E Schulz; Klaus Aktories
Journal:  J Biol Chem       Date:  2005-09-12       Impact factor: 5.157

2.  Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells.

Authors:  Maja Rupnik; Stefan Pabst; Marjan Rupnik; Christoph von Eichel-Streiber; Henning Urlaub; Hans-Dieter Söling
Journal:  Microbiology (Reading)       Date:  2005-01       Impact factor: 2.777

3.  Carbohydrate recognition by Clostridium difficile toxin A.

Authors:  Antonio Greco; Jason G S Ho; Shuang-Jun Lin; Monica M Palcic; Maja Rupnik; Kenneth K-S Ng
Journal:  Nat Struct Mol Biol       Date:  2006-04-16       Impact factor: 15.369

4.  Structural basis for the function of Clostridium difficile toxin B.

Authors:  Dirk J Reinert; Thomas Jank; Klaus Aktories; Georg E Schulz
Journal:  J Mol Biol       Date:  2005-09-02       Impact factor: 5.469

Review 5.  Hypervirulent strains of Clostridium difficile.

Authors:  Barry Cookson
Journal:  Postgrad Med J       Date:  2007-05       Impact factor: 2.401

6.  Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters.

Authors:  Barbara Geric; Robert J Carman; Maja Rupnik; Christopher W Genheimer; Susan P Sambol; David M Lyerly; Dale N Gerding; Stuart Johnson
Journal:  J Infect Dis       Date:  2006-03-06       Impact factor: 5.226

7.  R-Ras glucosylation and transient RhoA activation determine the cytopathic effect produced by toxin B variants from toxin A-negative strains of Clostridium difficile.

Authors:  Esteban Chaves-Olarte; Enrique Freer; Andrea Parra; Caterina Guzmán-Verri; Edgardo Moreno; Monica Thelestam
Journal:  J Biol Chem       Date:  2002-12-19       Impact factor: 5.157

8.  Cholesterol-dependent pore formation of Clostridium difficile toxin A.

Authors:  Torsten Giesemann; Thomas Jank; Ralf Gerhard; Elke Maier; Ingo Just; Roland Benz; Klaus Aktories
Journal:  J Biol Chem       Date:  2006-03-02       Impact factor: 5.157

9.  The large clostridial toxins from Clostridium sordellii and C. difficile repress glucocorticoid receptor activity.

Authors:  A Sasha Tait; Monique Dalton; Blandine Geny; Felice D'Agnillo; Michel R Popoff; Esther M Sternberg
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

10.  Clostridium difficile toxin expression is inhibited by the novel regulator TcdC.

Authors:  Susana Matamouros; Patrick England; Bruno Dupuy
Journal:  Mol Microbiol       Date:  2007-06       Impact factor: 3.501

View more
  3 in total

1.  Current Status of Nonantibiotic and Adjunct Therapies for Clostridium difficile Infection.

Authors:  Nuntra Suwantarat; David A Bobak
Journal:  Curr Infect Dis Rep       Date:  2011-02       Impact factor: 3.725

2.  Clostridium difficile toxin A promotes dendritic cell maturation and chemokine CXCL2 expression through p38, IKK, and the NF-kappaB signaling pathway.

Authors:  Jin Young Lee; Hyunah Kim; Mi Yeon Cha; Hong Gyu Park; Young-Jeon Kim; In Young Kim; Jung Mogg Kim
Journal:  J Mol Med (Berl)       Date:  2008-11-05       Impact factor: 4.599

3.  Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells.

Authors:  Pratik Banerjee; Glenn J Merkel; Arun K Bhunia
Journal:  Gut Pathog       Date:  2009-04-27       Impact factor: 4.181

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.